Berkeley Lights, Inc.

86 articles about Berkeley Lights, Inc.

• Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

  3/21/2023

  Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome.

• Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results

  2/23/2023

  Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.

• Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023

  2/13/2023

  Berkeley Lights, Inc., a life sciences tools company, announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023.

• Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development

  1/9/2023

  Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select™, the company's new optofluidic system for cell line development.

• Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference

  1/3/2023

  Berkeley Lights, Inc., a life sciences tools company, announced the Company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.

• Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

  12/21/2022

  Berkeley Lights and IsoPlexis announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.

• Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow

  11/18/2022

  Berkeley Lights, Inc., a leader in digital cell biology, announced the launch of the Opto® Memory B Discovery Rabbit workflow, expanding the diversity of antibodies customers can discover on the Beacon® platform.

• Berkeley Lights Reports Third Quarter 2022 Financial Results

  11/8/2022

  Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.

• Berkeley Lights to Report Third Quarter 2022 Financial Results on November 8, 2022

  10/18/2022

  Berkeley Lights, Inc., a leader in digital cell biology, announced that the Company will be reporting financial results for the third quarter 2022 after market on Tuesday, November 8, 2022.

• Berkeley Lights to Participate in the BioProcess International 2022 Conference

  9/21/2022

  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the Bioprocess International 2022 Conference (BPI) being held from September 27 - 30, 2022, at the Boston Convention and Exhibition Center.

• Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer

  9/19/2022

  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Scott Chaplin has been named the Company's chief legal officer and corporate secretary, effective immediately.

• Berkeley Lights Reports Second Quarter 2022 Financial Results

  8/9/2022

  Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended June 30, 2022.

• Berkeley Lights to Participate in the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit Conference

  8/3/2022

  Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit being held from August 15 - 18, 2022, virtually and at the Sheraton Boston in Boston, Massachusetts.

• Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide

  7/27/2022

  Berkeley Lights, Inc. and Aanika Biosciences today announced that the companies have successfully reached their strategic partnership milestone by identifying a commercially viable antimicrobial peptide (AMP) to enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne illness related recalls.

• Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer

  7/25/2022

  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO), effective immediately.  

• Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022

  7/21/2022

  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the second quarter 2022 after market on Tuesday, August 9, 2022.

• Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting

  6/22/2022

  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for Animal Cell Technology (ESCAT), being held from June 26 - 29, 2022 at the Lisbon Congress Centre in Lisbon, Portugal.

• Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities

  6/6/2022

  Berkeley Lights, Inc., a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its antibody-based drug discovery capabilities.

• Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022 

  4/26/2022

  Berkeley Lights, Inc., a leader in digital cell biology, announced that the Company will be reporting financial results for the first quarter 2022 after market on Monday, May 9, 2022.

• Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer

  3/9/2022

  Berkeley Lights, Inc. a leader in digital cell biology, announced it has appointed Dr. Siddhartha Kadia as its new chief executive officer, effective immediately.